Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2004 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
Weeraratna AT, Dalrymple SL, Lamb JC, Denmeade SR, Miknyoczki S, Dionne CA, Isaacs JT. Weeraratna AT, et al. Clin Cancer Res. 2001 Aug;7(8):2237-45. Clin Cancer Res. 2001. PMID: 11489797 Free article.
Rational basis for Trk inhibition therapy for prostate cancer.
Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT. Weeraratna AT, et al. Prostate. 2000 Oct 1;45(2):140-8. doi: 10.1002/1097-0045(20001001)45:2<140::aid-pros8>;2-#. Prostate. 2000. PMID: 11027413